Hypoxic Burden a cutting-edge metric measuring cumulative oxygen deprivation during sleephas emerged as a critical predictor of cardiovascular risks in sleep apnea patients
Association of prescription co-payment with adherence to glucagon-like peptide-1 receptor agonist and sodium-glucose cotransporter-2 inhibitor therapies in patients with heart failure and diabetes
[DOI] [PubMed] [Google Scholar] Yi Z, Yokota H, Torii S, Aoki T, Hosaka M, Zhao S, Takata K, Takeuchi T, Izumi T
Although non-melanoma skin cancers such as basal cell carcinomas and squamous cell carcinomas are rarely fatal, the findings suggest patients with these conditions have an additional risk of melanoma, breast and lung cancers
SURMOUNT-OSA (reduction in apnoeahypopnea in obstructive sleep apnoea) Survodutide : MASH trial (resolution of MASH, improvement in fibrosis) Another key event in 2024 was the readout of the first head-to-head trial in obesity, Lillys SURMOUNT-5, pitting tirzepatide against semaglutide, with the former demonstrating superior weight loss